Additional bacillus Calmette-Guerin therapy for recurrent transitional cell carcinoma after an initial complete response

Author： Bui T.T. Schellhammer P.F.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.49, Iss.5, 1997-05, pp. : 687-691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In situ transitional cell carcinoma involvement of prostatic urethra: Bacillus Calmette-Guerin therapy without previous transurethral resection of the prostate

By Palou J. Xavier B. Laguna P. Montlleo M. Vicente J.

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 482-484

Elsevier

Access to resources Recommend Favorite

Significance of p53 overexpression in urinary bladder transitional cell carcinoma in situ before and after bacillus Calmette-Guerin treatment

By Ick K. Schultz M. Stout P. Fan K.

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 541-547

Elsevier

Access to resources Recommend Favorite

Stage T1 Adenocarcinoma of the Urinary Bladder: Complete Response after Transurethral Resection and Intravesical Bacillus Calmette-Guerin

By Holmäng Sten Aldenborg Frank

Scandinavian Journal of Urology and Nephrology, Vol. 34, Iss. 2, 2000-08 ,pp. : 141-143

Informa Healthcare

Access to resources Recommend Favorite

Intravesical bacillus Calmette-Guerin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder - 15 years outcome

By Baniel J. Grauss D. Engelstein D. Sella A.

Urology, Vol. 52, Iss. 5, 1998-11 ,pp. : 785-789

Elsevier

Access to resources Recommend Favorite

Definitive tumor resection and percutaneous bacille Calmette-Guerin for management of renal pelvic transitional cell carcinoma in solitary kidneys

By Vasavada S.P. Streem S.B. Novick A.C.

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 381-386

Elsevier

Access to resources Recommend Favorite